Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Keith Lindor

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Liver

Procedures

Concepts & Ideas

Physiology

Disease Progression

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Elfaki D A H; Bjornsson E; Lindor K D
Review article: nuclear receptors and liver disease--current understanding and new therapeutic implications.
Lindor Keith D; Kowdley Kris V; Luketic Velimir A C; Harrison M Edwyn; McCashland Timothy; Befeler Alex S; Harnois Denise; Jorgensen Roberta; Petz Jan; Keach Jill; Mooney Jody; Sargeant Carol; Braaten Julie; Bernard Tamara; King Debra; Miceli Ellen; Schmoll Jeff; Hoskin Tanya; Thapa Prabin; Enders Felicity
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Silveira Marina G; Mendes Flavia D; Diehl Nancy N; Enders Felicity T; Lindor Keith D
Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Keith Lindor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Elfaki D A H; Bjornsson E; Lindor K D
Review article: nuclear receptors and liver disease--current understanding and new therapeutic implications.
Alimentary pharmacology & therapeutics 2009;30(8):816-25.
2009: Lindor Keith D; Kowdley Kris V; Luketic Velimir A C; Harrison M Edwyn; McCashland Timothy; Befeler Alex S; Harnois Denise; Jorgensen Roberta; Petz Jan; Keach Jill; Mooney Jody; Sargeant Carol; Braaten Julie; Bernard Tamara; King Debra; Miceli Ellen; Schmoll Jeff; Hoskin Tanya; Thapa Prabin; Enders Felicity
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2009;50(3):808-14.
2009: Silveira Marina G; Mendes Flavia D; Diehl Nancy N; Enders Felicity T; Lindor Keith D
Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(7):1094-100.
2009: Lindor Keith D; Gershwin M Eric; Poupon Raoul; Kaplan Marshall; Bergasa Nora V; Heathcote E Jenny;
Primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2009;50(1):291-308.
2009: Silveira Marina G; Lindor Keith D
38-year-old woman with abnormal liver enzymes and hyperlipidemia.
Mayo Clinic proceedings. Mayo Clinic 2009;84(6):551-4.
2009: Bangarulingam Sanjay Y; Gossard Andrea A; Petersen Bret T; Ott Beverly J; Lindor Keith D
Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.
The American journal of gastroenterology 2009;104(4):855-60.
2009: Lindor Keith D
A new section: image of the month.
Hepatology (Baltimore, Md.) 2009;49(2):344.
2009: Abbas Ghulam; Lindor Keith D
Cholangiocarcinoma in primary sclerosing cholangitis.
Journal of gastrointestinal cancer 2009;40(1-2):19-25.
2008: Dyrbye Liselotte N; Lindor Keith D; LaRusso Nicholas F; Cook David A
Research productivity of graduates from 3 physician-scientist training programs.
The American journal of medicine 2008;121(12):1107-13.
2008: Lindor Keith D
Dr. H. Butt tribute.
Hepatology (Baltimore, Md.) 2008;48(4):1027.
2008: Silveira Marina G; Suzuki Ayako; Lindor Keith D
Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2008;48(4):1149-56.
2008: Charatcharoenwitthaya Phunchai; Enders Felicity B; Halling Kevin C; Lindor Keith D
Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2008;48(4):1106-17.
2008: Silveira Marina-G; Lindor Keith-D
Clinical features and management of primary sclerosing cholangitis.
World journal of gastroenterology : WJG 2008;14(21):3338-49.
2008: Mendes Flavia; Lindor Keith D
Antimitochondrial antibody-negative primary biliary cirrhosis.
Gastroenterology clinics of North America 2008;37(2):479-84, viii.
2008: Angulo Paul; Jorgensen Roberta A; Kowdley Kris V; Lindor Keith D
Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study.
Digestive diseases and sciences 2008;53(6):1716-20.
2008: Silveira Marina G; Lindor Keith D
Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Clinics in liver disease 2008;12(2):425-43; x-xi.
2008: Silveira Marina G; Lindor Keith D
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Journal of hepatology 2008;48(5):692-4.
2008: Mendes Flavia D; Kim W Ray; Pedersen Rachel; Therneau Terry; Lindor Keith D
Mortality attributable to cholestatic liver disease in the United States.
Hepatology (Baltimore, Md.) 2008;47(4):1241-7.
2008: Chahal Prabhleen; Levy Cynthia; Litzow Mark R; Lindor Keith D
Utility of liver biopsy in bone marrow transplant patients.
Journal of gastroenterology and hepatology 2008;23(2):222-5.
2008: Charatcharoenwitthaya Phunchai; Lindor Keith D
Recurrence of primary sclerosing cholangitis: what do we learn from several transplant centers?
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(2):130-2.
2008: Charlton Michael; Angulo Paul; Chalasani Naga; Merriman Ralph; Viker Kimberly; Charatcharoenwitthaya Phunchai; Sanderson Schuyler; Gawrieh Samer; Krishnan Anuradha; Lindor Keith
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2008;47(2):484-92.
2008: Charatcharoenwitthaya Phunchai; Angulo Paul; Enders Felicity B; Lindor Keith D
Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2008;47(1):133-42.
2008: Elfaki Diaa H; Gossard Andrea A; Lindor Keith D
Cholangiocarcinoma: expanding the spectrum of risk factors.
Journal of gastrointestinal cancer 2008;39(1-4):114-7.
2007: Selmi Carlo; Gershwin M Eric; Lindor Keith D; Worman Howard J; Gold Ellen B; Watnik Mitchell; Utts Jessica; Invernizzi Pietro; Kaplan Marshall M; Vierling John M; Bowlus Christopher L; Silveira Marina G; Bossi Ilaria;
Quality of life and everyday activities in patients with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2007;46(6):1836-43.
2007: Viggiano Thomas R; Pawlina Wojciech; Lindor Keith D; Olsen Kerry D; Cortese Denis A
Putting the needs of the patient first: Mayo Clinic's core value, institutional culture, and professionalism covenant.
Academic medicine : journal of the Association of American Medical Colleges 2007;82(11):1089-93.
2007: Adams Leon A; Lindor Keith D
Nonalcoholic fatty liver disease.
Annals of epidemiology 2007;17(11):863-9.
2007: Lindor Keith D
Characteristics of primary sclerosing cholangitis in the USA.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37 Suppl 3():S474-7.
2007: Lindor Keith
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
The New England journal of medicine 2007;357(15):1524-9.
2007: Gossard Andrea A; Lindor Keith D
Development of autoimmune hepatitis in primary biliary cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(8):1086-90.
2007: Charatcharoenwitthaya Phunchai; Pimentel Sylvania; Talwalkar Jayant A; Enders Felicity T; Lindor Keith D; Krom Ruud A F; Wiesner Russell H
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(9):1236-45.
2007: Nelson James E; Bhattacharya Renuka; Lindor Keith D; Chalasani Naga; Raaka Stuart; Heathcote E Jenny; Miskovsky Emil; Shaffer Eldon; Rulyak Stephen J; Kowdley Kris V
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2007;46(3):723-9.
2007: Lazaridis Konstantinos N; Juran Brian D; Boe Gwen M; Slusser Joshua P; de Andrade Mariza; Homburger Henry A; Ghosh Karthik; Dickson E Rolland; Lindor Keith D; Petersen Gloria M
Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2007;46(3):785-92.
2007: Suzuki Ayako; Angulo Paul; St Sauver Jennifer; Muto Ayako; Okada Toshihide; Lindor Keith
Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia.
The American journal of gastroenterology 2007;102(9):1912-9.
2007: Panjala Chakri; Talwalkar Jayant A; Lindor Keith D
Risk of lymphoma in primary biliary cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(6):761-4.
2007: Silveira Marina G; Talwalkar Jayant A; Angulo Paul; Lindor Keith D
Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.
The American journal of gastroenterology 2007;102(6):1244-50.
2007: Angulo Paul; Hui Jason M; Marchesini Giulio; Bugianesi Ellisabetta; George Jacob; Farrell Geoffrey C; Enders Felicity; Saksena Sushma; Burt Alastair D; Bida John P; Lindor Keith; Sanderson Schuyler O; Lenzi Marco; Adams Leon A; Kench James; Therneau Terry M; Day Christopher P
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
Hepatology (Baltimore, Md.) 2007;45(4):846-54.
2007: Charatcharoenwitthaya Phunchai; Levy Cynthia; Angulo Paul; Keach Jill; Jorgensen Roberta; Lindor Keith D
Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(2):220-6.
2007: Charatcharoenwitthaya Phunchai; Lindor Keith D
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
Clinics in liver disease 2007;11(1):37-54, viii.
2007: Suzuki Ayako; Lymp James; Donlinger Jessica; Mendes Flavia; Angulo Paul; Lindor Keith
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(2):259-64.
2007: Mendes Flavia D; Levy Cynthia; Enders Felicity B; Loftus Edward V; Angulo Paul; Lindor Keith D
Abnormal hepatic biochemistries in patients with inflammatory bowel disease.
The American journal of gastroenterology 2007;102(2):344-50.
2007: Charatcharoenwitthaya Phunchai; Lindor Keith D
Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(1):32-6.
2007: Steele Ian L; Levy Cynthia; Lindor Keith D
Primary sclerosing cholangitis--approach to diagnosis.
MedGenMed : Medscape general medicine 2007;9(2):20.
2006: Suzuki Ayako; Lymp James; Sauver Jenny St; Angulo Paul; Lindor Keith
Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(10):1209-16.
2006: Talwalkar Jayant A; Donlinger Jessica J; Gossard Andrea A; Keach Jill C; Jorgensen Roberta A; Petz Janice C; Lindor Keith D
Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.
Digestive diseases and sciences 2006;51(11):1985-91.
2006: Mendes Flavia D; Jorgensen Roberta; Keach Jill; Katzmann Jerry A; Smyrk Thomas; Donlinger Jessica; Chari Suresh; Lindor Keith D
Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
The American journal of gastroenterology 2006;101(9):2070-5.
2006: Charatcharoenwitthaya Phunchai; Lindor Keith D
Primary sclerosing cholangitis: diagnosis and management.
Current gastroenterology reports 2006;8(1):75-82.
2006: Levy Cynthia; Lindor Keith D
Primary sclerosing cholangitis: epidemiology, natural history, and prognosis.
Seminars in liver disease 2006;26(1):22-30.
2005: Suzuki Ayako; Lindor Keith; St Saver Jenny; Lymp James; Mendes Flavia; Muto Ayako; Okada Toshihide; Angulo Paul
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.
Journal of hepatology 2005;43(6):1060-6.
2005: Gershwin M Eric; Selmi Carlo; Worman Howard J; Gold Ellen B; Watnik Mitchell; Utts Jessica; Lindor Keith D; Kaplan Marshall M; Vierling John M;
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.
Hepatology (Baltimore, Md.) 2005;42(5):1194-202.
2005: Zein Claudia O; Jorgensen Roberta A; Clarke Bart; Wenger Doris E; Keach Jill C; Angulo Paul; Lindor Keith D
Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.
Hepatology (Baltimore, Md.) 2005;42(4):762-71.
2005: Levy Cynthia; Lymp James; Angulo Paul; Gores Gregory J; Larusso Nicholas; Lindor Keith D
The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.
Digestive diseases and sciences 2005;50(9):1734-40.
2005: Charatcharoenwitthaya Phunchai; Lindor Keith D
Current concepts in the pathogenesis of primary biliary cirrhosis.
Annals of hepatology : official journal of the Mexican Association of Hepatology 2005;4(3):161-75.
2005: Adams Leon A; Lymp James F; St Sauver Jenny; Sanderson Schuyler O; Lindor Keith D; Feldstein Ariel; Angulo Paul
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
Gastroenterology 2005;129(1):113-21.
2005: Gossard Andrea A; Angulo Paul; Lindor Keith D
Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.
The American journal of gastroenterology 2005;100(6):1330-3.
2005: Adams Leon A; Angulo Paul; Lindor Keith D
Nonalcoholic fatty liver disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(7):899-905.
2005: Bloch Donald B; Yu Jiang Hong; Yang Wei-Hong; Graeme-Cook Fiona; Lindor Keith D; Viswanathan Anjali; Bloch Kenneth D; Nakajima Ayako
The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis.
The Journal of rheumatology 2005;32(3):477-83.
2005: Suzuki Ayako; Mendes Flavia; Lindor Keith
Diagnostic model of esophageal varices in alcoholic liver disease.
European journal of gastroenterology & hepatology 2005;17(3):307-9.
2005: Levy Cynthia; Harnois Denise M; Angulo Paul; Jorgensen Roberta; Lindor Keith D
Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(1):117-21.
2005: Talwalkar Jayant A; Angulo Paul; Keach Jill C; Petz Janice L; Jorgensen Roberta A; Lindor Keith D
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Journal of clinical gastroenterology 2005;39(2):168-71.
2005: Talwalkar Jayant A; Angulo Paul; Keach Jill C; Petz Janice L; Jorgensen Roberta A; Lindor Keith D
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
The American journal of gastroenterology 2005;100(2):308-12.
2005: Mendes Flavia D; Lindor Keith D
Recent advances in the treatment of non-alcoholic fatty liver disease.
Expert opinion on investigational drugs 2005;14(1):29-35.
2005: Heimbach Julie K; Menon K V Narayanan; Ishitani Michael B; Nyberg Scott L; Jankowski Christopher J; Lindor Keith D; Rosen Charles B
Living donor liver transplantation using a right lobe graft in an adult with situs inversus.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(1):111-3.
2005: Suzuki Ayako; Angulo Paul; Lymp James; St Sauver Jennifer; Muto Ayako; Okada Toshihide; Lindor Keith
Chronological development of elevated aminotransferases in a nonalcoholic population.
Hepatology (Baltimore, Md.) 2005;41(1):64-71.
2005: Talwalkar Jayant A; Lindor Keith D
Primary sclerosing cholangitis.
Inflammatory bowel diseases 2005;11(1):62-72.
2005: Adams Leon A; Sanderson Schuyler; Lindor Keith D; Angulo Paul
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
Journal of hepatology 2005;42(1):132-8.
2004: Yang Wei-Hong; Yu Jiang Hong; Nakajima Ayako; Neuberg Donna; Lindor Keith; Bloch Donald B
Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(12):1116-22.
2004: Angulo Paul; Alba Laura M; Petrovic Lydia M; Adams Leon A; Lindor Keith D; Jensen Michael D
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
Journal of hepatology 2004;41(6):943-9.
2004: Adams Leon A; Zein Claudia O; Angulo Paul; Lindor Keith D
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.
The American journal of gastroenterology 2004;99(12):2365-8.
2004: Ghali Peter; Lindor Keith D
Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.
Seminars in liver disease 2004;24(4):389-97.
2004: Levy Cynthia; Seeff Leonard D; Lindor Keith D
Use of herbal supplements for chronic liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(11):947-56.
2004: Adams Leon A; Lindor Keith D
Treatment of hyperlipidemia in nonalcoholic fatty liver disease: fat for thought.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2004;23(4):127-8.
2004: Talwalkar Jayant A; Angulo Paul; Johnson C Daniel; Petersen Bret T; Lindor Keith D
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2004;40(1):39-45.
2004: Adams Leon A; Lindor Keith D; Angulo Paul
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.
The American journal of gastroenterology 2004;99(7):1316-20.
2004: Adams Leon A; Feldstein Ariel; Lindor Keith D; Angulo Paul
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
Hepatology (Baltimore, Md.) 2004;39(4):909-14.
2004: Abdulkarim Ahmad S; Petrovic Lydia M; Kim Woong R; Angulo Paul; Lloyd Ricardo V; Lindor Keith D
Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?
Journal of hepatology 2004;40(3):380-4.
2004: Maddala Yamini K; Jorgensen Roberta A; Angulo Paul; Lindor Keith D
Open-label pilot study of tetracycline in the treatment of primary biliary cirrhosis.
The American journal of gastroenterology 2004;99(3):566-7.
2004: Burak Kelly; Angulo Paul; Pasha Tousif M; Egan Kathleen; Petz Jan; Lindor Keith D
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
The American journal of gastroenterology 2004;99(3):523-6.
2004: Lindor Keith D; Kowdley Kris V; Heathcote E Jenny; Harrison M Edwyn; Jorgensen Roberta; Angulo Paul; Lymp James F; Burgart Lawrence; Colin Patrick
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
Hepatology (Baltimore, Md.) 2004;39(3):770-8.
2004: Mendes Flavia D; Lindor Keith D
Primary sclerosing cholangitis.
Clinics in liver disease 2004;8(1):195-211.
2004: Zein Claudia O; Lindor Keith D; Angulo Paul
Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2004;39(1):204-10.
2003: Siegel Joanna L; Luthra Harvinder; Donlinger Jessica; Angulo Paul; Lindor Keith
Association of primary biliary cirrhosis and rheumatoid arthritis.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2003;9(6):340-3.
2003: Levy Cynthia; Lindor Keith D
Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis.
Clinics in liver disease 2003;7(4):901-10.
2003: Phillips Jason R; Angulo Paul; Lindor Keith
Recurrent idiopathic hepatitis: a new entity?
Journal of clinical gastroenterology 2003;37(3):267-9.
2003: Feldstein Ariel E; Canbay Ali; Angulo Paul; Taniai Makiko; Burgart Lawrence J; Lindor Keith D; Gores Gregory J
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
Gastroenterology 2003;125(2):437-43.
2003: Siegel Joanna L; Jorgensen Roberta; Angulo Paul; Lindor Keith D
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis.
Journal of clinical gastroenterology 2003;37(2):183-5.
2003: Talwalkar Jayant A; Souto Enrico; Jorgensen Roberta A; Lindor Keith D
Natural history of pruritus in primary biliary cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2003;1(4):297-302.
2003: Talwalkar Jayant A; Lindor Keith D
Primary biliary cirrhosis.
Lancet 2003;362(9377):53-61.
2003: Feldstein Ariel E; Perrault Jean; El-Youssif Mounif; Lindor Keith D; Freese Deborah K; Angulo Paul
Primary sclerosing cholangitis in children: a long-term follow-up study.
Hepatology (Baltimore, Md.) 2003;38(1):210-7.
2003: Poupon Renée Eugénie; Lindor Keith D; Parés Albert; Chazouillères Olivier; Poupon Raoul; Heathcote E Jenny
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.
Journal of hepatology 2003;39(1):12-6.
2003: Stadheim Linda M; O'Brien John F; Lindor Keith D; Gores Gregory J; McGill Douglas B
Value of determining carbohydrate-deficient transferrin isoforms in the diagnosis of alcoholic liver disease.
Mayo Clinic proceedings. Mayo Clinic 2003;78(6):703-7.
2003: Levy Cynthia; Lindor Keith D
Drug-induced cholestasis.
Clinics in liver disease 2003;7(2):311-30.
2003: Burak Kelly W; Angulo Paul; Lindor Keith D
Is there a role for liver biopsy in primary sclerosing cholangitis?
The American journal of gastroenterology 2003;98(5):1155-8.
2003: Menon K V Narayanan; Angulo Paul; Boe Gwen M; Lindor Keith D
Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
The American journal of gastroenterology 2003;98(4):889-92.
2003: Alba L M; Lindor K
Review article: Non-alcoholic fatty liver disease.
Alimentary pharmacology & therapeutics 2003;17(8):977-86.
2003: Pardi Darrell S; Loftus Edward V; Kremers Walter K; Keach Jill; Lindor Keith D
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
Gastroenterology 2003;124(4):889-93.
2003: Zein Claudia O; Angulo Paul; Lindor Keith D
When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2003;1(2):89-95.
2003: Bach Nancy; Bodian Carol; Bodenheimer Henry; Croen Edward; Berk Paul D; Thung Swan N; Lindor Keith D; Therneau Thierry; Schaffner Fenton
Methotrexate therapy for primary biliary cirrhosis.
The American journal of gastroenterology 2003;98(1):187-93.
2003: Levy Cynthia; Lindor Keith D
Current management of primary biliary cirrhosis and primary sclerosing cholangitis.
Journal of hepatology 2003;38 Suppl 1():S24-37.
2002: Brandt Terry L; Romme Clifford R; LaRusso Nicholas F; Lindor Keith D
A novel incentive system for faculty in an academic medical center.
Annals of internal medicine 2002;137(9):738-43.
2002: Angulo Paul; Lindor Keith D
Treatment of non-alcoholic steatohepatitis.
Best practice & research. Clinical gastroenterology 2002;16(5):797-810.
2002: Jorgensen Roberta; Angulo Paul; Dickson E Rolland; Lindor Keith D
Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.
The American journal of gastroenterology 2002;97(10):2647-50.
2002: Gossard Andrea A; Lindor Keith D
Pregnancy in a patient with primary sclerosing cholangitis.
Journal of clinical gastroenterology 2002;35(4):353-5.
2002: Alba L M; Angulo P; Lindor K D
Primary sclerosing cholangitis.
Minerva gastroenterologica e dietologica 2002;48(2):99-113.
2002: Suzuki Ayako; Van de Water Judy; Gershwin M Eric; Jorgensen Roberta; Angulo Paul; Lindor Keith
Oral tolerance and pyruvate dehydrogenase in patients with primary biliary cirrhosis.
Developmental immunology 2002;9(2):55-61.
2002: Angulo Paul; Maor-Kendler Yaakov; Lindor Keith D
Small-duct primary sclerosing cholangitis: a long-term follow-up study.
Hepatology (Baltimore, Md.) 2002;35(6):1494-500.
2002: Talwalkar Jayant A; Lindor Keith D
Sclerosing cholangitis.
Current opinion in gastroenterology 2002;18(3):372-7.
2002: Talwalkar Jayant A; Keach Jill C; Angulo Paul; Lindor Keith D
Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system.
The American journal of gastroenterology 2002;97(5):1191-7.
2002: Buckles Daniel C; Lindor Keith D; Larusso Nicholas F; Petrovic Lydia M; Gores Gregory J
In primary sclerosing cholangitis, gallbladder polyps are frequently malignant.
The American journal of gastroenterology 2002;97(5):1138-42.
2002: Joshi Supriya; Cauch-Dudek Karen; Heathcote E Jenny; Lindor Keith; Jorgensen Roberta; Klein Reinhild
Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?
The American journal of gastroenterology 2002;97(4):999-1002.
2002: Charlton Michael; Sreekumar Raghavakaimal; Rasmussen Deborah; Lindor Keith; Nair K Sreekumaran
Apolipoprotein synthesis in nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2002;35(4):898-904.
2002: Angulo Paul; Lindor Keith D
Non-alcoholic fatty liver disease.
Journal of gastroenterology and hepatology 2002;17 Suppl():S186-90.
2002: Neuman Manuela; Angulo Paul; Malkiewicz Izabella; Jorgensen Roberta; Shear Neil; Dickson E Rolland; Haber Julia; Katz Gady; Lindor Keith
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis.
Journal of gastroenterology and hepatology 2002;17(2):196-202.
2002: Joshi Supriya; Cauch-Dudek Karen; Wanless Ian R; Lindor Keith D; Jorgensen Roberta; Batts Kenneth; Heathcote E Jenny
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2002;35(2):409-13.
2002: Angulo Paul; MacCarty Robert L; Sylvestre Pamela B; Jorgensen Roberta A; Wiesner Russell H; LaRusso Nicholas A; Lindor Keith D
Pirfenidone in the treatment of primary sclerosing cholangitis.
Digestive diseases and sciences 2002;47(1):157-61.
2002: Stone Julianne; Wade Judy A; Cauch-Dudek Karen; Ng Chang; Lindor Keith D; Heathcote E Jenny
Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis.
Journal of hepatology 2002;36(1):8-13.
2001: Angulo P; Jorgensen R A; Lindor K D
Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
The American journal of gastroenterology 2001;96(11):3152-7.
2001: Nehra V; Angulo P; Buchman A L; Lindor K D
Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.
Digestive diseases and sciences 2001;46(11):2347-52.
2001: Angulo P; El-Amin O; Carpenter H A; Lindor K D
Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis.
The American journal of gastroenterology 2001;96(10):3021-7.
2001: Menon K V; Angulo P; Weston S; Dickson E R; Lindor K D
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.
Journal of hepatology 2001;35(3):316-23.
2001: Phillips J R; Angulo P; Petterson T; Lindor K D
Fat-soluble vitamin levels in patients with primary biliary cirrhosis.
The American journal of gastroenterology 2001;96(9):2745-50.
2001: Abdelmalek M F; Angulo P; Jorgensen R A; Sylvestre P B; Lindor K D
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
The American journal of gastroenterology 2001;96(9):2711-7.
2001: Talwalkar J A; Lindor K D
Natural history and prognostic models in primary sclerosing cholangitis.
Best practice & research. Clinical gastroenterology 2001;15(4):563-75.
2001: Lazaridis K N; Gores G J; Lindor K D
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.
Journal of hepatology 2001;35(1):134-46.
2001: Charlton M; Kasparova P; Weston S; Lindor K; Maor-Kendler Y; Wiesner R H; Rosen C B; Batts K P
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2001;7(7):608-14.
2001: Menon KVN; Angulo P; Lindor K D
Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.
The American journal of gastroenterology 2001;96(5):1631-4.
2001: Harnois D M; Angulo P; Jorgensen R A; Larusso N F; Lindor K D
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
The American journal of gastroenterology 2001;96(5):1558-62.
2001: Zein C O; Lindor K D
Primary sclerosing cholangitis.
Seminars in gastrointestinal disease 2001;12(2):103-12.
2001: Kaya M; de Groen P C; Angulo P; Nagorney D M; Gunderson L L; Gores G J; Haddock M G; Lindor K D
Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.
The American journal of gastroenterology 2001;96(4):1164-9.
2001: Kaya M; Petersen B T; Angulo P; Baron T H; Andrews J C; Gostout C J; Lindor K D
Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.
The American journal of gastroenterology 2001;96(4):1059-66.
2001: Scolapio J S; Gostout C J; Schroeder K W; Mahoney D W; Lindor K D
Dysphagia without endoscopically evident disease: to dilate or not?
The American journal of gastroenterology 2001;96(2):327-30.
2001: Angulo P; Lindor K D
Treatment of nonalcoholic fatty liver: present and emerging therapies.
Seminars in liver disease 2001;21(1):81-8.
2000: Lindor K D; Jorgensen R A; Tiegs R D; Khosla S; Dickson E R
Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial.
Journal of hepatology 2000;33(6):878-82.
2000: Kim W R; Lindor K D; Locke G R; Therneau T M; Homburger H A; Batts K P; Yawn B P; Petz J L; Melton L J; Dickson E R
Epidemiology and natural history of primary biliary cirrhosis in a US community.
Gastroenterology 2000;119(6):1631-6.
2000: Sorbi D; McGill D B; Thistle J L; Therneau T M; Henry J; Lindor K D
An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities.
The American journal of gastroenterology 2000;95(11):3206-10.
2000: Czaja A J; Lindor K D
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis.
Gastroenterology 2000;119(5):1312-6.
2000: Kim W R; Lindor K D; Malinchoc M; Petz J L; Jorgensen R; Dickson E R
Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease.
Hepatology (Baltimore, Md.) 2000;32(5):924-9.
2000: Angulo P; Patel T; Jorgensen R A; Therneau T M; Lindor K D
Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2000;32(5):897-900.
2000: Kaya M; Angulo P; Lindor K D
Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system.
Journal of hepatology 2000;33(4):537-42.
2000: Angulo P; Pearce D H; Johnson C D; Henry J J; LaRusso N F; Petersen B T; Lindor K D
Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis.
Journal of hepatology 2000;33(4):520-7.
2000: Fong D G; Angulo P; Burgart L J; Lindor K D
Cetirizine-induce cholestasis.
Journal of clinical gastroenterology 2000;31(3):250-3.
2000: Angulo P; Lindor K D
Medical treatment for primary sclerosing cholangitis: risk versus benefit.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):871-2.
2000: Bharucha A E; Jorgensen R; Lichtman S N; LaRusso N F; Lindor K D
A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis.
The American journal of gastroenterology 2000;95(9):2338-42.
2000: Angulo P; Batts K P; Jorgensen R A; LaRusso N A; Lindor K D
Oral budesonide in the treatment of primary sclerosing cholangitis.
The American journal of gastroenterology 2000;95(9):2333-7.
2000: Kim W R; Therneau T M; Wiesner R H; Poterucha J J; Benson J T; Malinchoc M; LaRusso N F; Lindor K D; Dickson E R
A revised natural history model for primary sclerosing cholangitis.
Mayo Clinic proceedings. Mayo Clinic 2000;75(7):688-94.
2000: Fong D G; Nehra V; Lindor K D; Buchman A L
Metabolic and nutritional considerations in nonalcoholic fatty liver.
Hepatology (Baltimore, Md.) 2000;32(1):3-10.
2000: Kim W R; Ludwig J; Lindor K D
Variant forms of cholestatic diseases involving small bile ducts in adults.
The American journal of gastroenterology 2000;95(5):1130-8.
2000: Lazaridis K N; Lindor K D
Management of primary biliary cirrhosis: from diagnosis to end-stage disease.
Current gastroenterology reports 2000;2(2):94-8.
2000: Tanaka A; Lindor K; Ansari A; Gershwin M E
Fetal microchimerisms in the mother: immunologic implications.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000;6(2):138-43.
2000: Angulo P; Peter J B; Gershwin M E; DeSotel C K; Shoenfeld Y; Ahmed A E; Lindor K D
Serum autoantibodies in patients with primary sclerosing cholangitis.
Journal of hepatology 2000;32(2):182-7.
2000: Angulo P; Jorgensen R A; Keach J C; Dickson E R; Smith C; Lindor K D
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2000;31(2):318-23.
2000: Reynoso-Paz S; Leung P S; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald P J; Coppel R L; Ansari A A; Gershwin M E
Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2000;31(1):24-9.
1999: Sorbi D; Gostout C J; Henry J; Lindor K D
Unsedated small-caliber esophagogastroduodenoscopy (EGD) versus conventional EGD: a comparative study.
Gastroenterology 1999;117(6):1301-7.
1999: Czaja A J; Carpenter H A; Lindor K D
Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
Hepatology (Baltimore, Md.) 1999;30(6):1381-6.
1999: Angulo P; Keach J C; Batts K P; Lindor K D
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 1999;30(6):1356-62.
1999: Angulo P; Larson D R; Therneau T M; LaRusso N F; Batts K P; Lindor K D
Time course of histological progression in primary sclerosing cholangitis.
The American journal of gastroenterology 1999;94(11):3310-3.
1999: Tanaka A; Lindor K; Gish R; Batts K; Shiratori Y; Omata M; Nelson J L; Ansari A; Coppel R; Newsome M; Gershwin M E
Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;30(4):833-8.
1999: Angulo P; Lindor K D
Primary biliary cirrhosis and primary sclerosing cholangitis.
Clinics in liver disease 1999;3(3):529-70.
1999: Weston S R; Jorgensen R A; Dickson E R; Lindor K D
Is routine cholangiography useful in men with suspected primary biliary cirrhosis?
Journal of clinical gastroenterology 1999;29(1):68-70.
1999: Heathcote E J; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor K D; Petz J; Dickson E R; Poupon R E
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1999;5(4):269-74.
1999: Scolapio J S; Pasha T M; Gostout C J; Mahoney D W; Zinsmeister A R; Ott B J; Lindor K D
A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings.
Gastrointestinal endoscopy 1999;50(1):13-7.
1999: Angulo P; Lindor K D
Primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 1999;30(1):325-32.
1999: Yamazaki K; Suzuki K; Nakamura A; Sato S; Lindor K D; Batts K P; Tarara J E; Kephart G M; Kita H; Gleich G J
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;30(1):71-8.
1999: Kim W R; Poterucha J J; Wiesner R H; LaRusso N F; Lindor K D; Petz J; Therneau T M; Malinchoc M; Dickson E R
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 1999;29(6):1643-8.
1999: Angulo P; Dickson E R; Therneau T M; Jorgensen R A; Smith C; DeSotel C K; Lange S M; Anderson M L; Mahoney D W; Lindor K D
Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.
Journal of hepatology 1999;30(5):830-5.
1999: Nijhawan P K; Therneau T M; Dickson E R; Boynton J; Lindor K D
Incidence of cancer in primary biliary cirrhosis: the Mayo experience.
Hepatology (Baltimore, Md.) 1999;29(5):1396-8.
1999: Angulo P; Lindor K D; Therneau T M; Jorgensen R A; Malinchoc M; Kamath P S; Dickson E R
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.
Liver 1999;19(2):115-21.
1999: Sorbi D; Boynton J; Lindor K D
The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
The American journal of gastroenterology 1999;94(4):1018-22.
1999: Angulo P; Bharucha A E; Jorgensen R A; DeSotel C K; Sandborn W J; Larusso N F; Lindor K D
Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study.
Digestive diseases and sciences 1999;44(3):602-7.
1999: Angulo P; Batts K P; Therneau T M; Jorgensen R A; Dickson E R; Lindor K D
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;29(3):644-7.
1999: Pasha T; Heathcote J; Gabriel S; Cauch-Dudek K; Jorgensen R; Therneau T; Dickson E R; Lindor K D
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;29(1):21-6.
1998: Angulo P; Therneau T M; Jorgensen A; DeSotel C K; Egan K S; Dickson E R; Hay J E; Lindor K D
Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.
Journal of hepatology 1998;29(5):729-35.
1998: Lindor K D; Lacerda M A; Jorgensen R A; DeSotel C K; Batta A K; Salen G; Dickson E R; Rossi S S; Hofmann A F
Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
The American journal of gastroenterology 1998;93(9):1498-504.
1998: Zukowski T H; Jorgensen R A; Dickson E R; Lindor K D
Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy.
The American journal of gastroenterology 1998;93(6):958-61.
1998: Ricci P; Hofmann A F; Hagey L R; Jorgensen R A; Rolland Dickson E; Lindor K D
Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
Digestive diseases and sciences 1998;43(6):1292-5.
1998: Angulo P; Lindor K D
Management of primary biliary cirrhosis and autoimmune cholangitis.
Clinics in liver disease 1998;2(2):333-51, ix.
1998: Pasha T; Gabriel S; Therneau T; Dickson E R; Lindor K D
Cost-effectiveness of ultrasound-guided liver biopsy.
Hepatology (Baltimore, Md.) 1998;27(5):1220-6.
1998: Abdelmalek M F; Harrison M E; Gross J B; Poterucha J J; Gossard A A; Spivey J R; Rakela J; Lindor K D
Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial.
Journal of clinical gastroenterology 1998;26(2):130-4.
1997: Lindor K D; Jorgensen R A; Therneau T M; Malinchoc M; Dickson E R
Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis.
Mayo Clinic proceedings. Mayo Clinic 1997;72(12):1137-40.
1997: Poupon R E; Lindor K D; Cauch-Dudek K; Dickson E R; Poupon R; Heathcote E J
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.
Gastroenterology 1997;113(3):884-90.
1997: Lindor K D
Early primary biliary cirrhosis: just delayed or different?
Hepatology (Baltimore, Md.) 1997;26(1):239-41.
1997: Kim W R; Poterucha J J; Jorgensen R A; Batts K P; Homburger H A; Dickson E R; Krom R A; Wiesner R H; Lindor K D
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Hepatology (Baltimore, Md.) 1997;26(1):22-6.
1996: Pasha T M; Lindor K D
Diagnosis and therapy of cholestatic liver disease.
The Medical clinics of North America 1996;80(5):995-1019.
1996: Laurin J; Lindor K D; Crippin J S; Gossard A; Gores G J; Ludwig J; Rakela J; McGill D B
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Hepatology (Baltimore, Md.) 1996;23(6):1464-7.
1996: Lindor K D; Therneau T M; Jorgensen R A; Malinchoc M; Dickson E R
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis.
Gastroenterology 1996;110(5):1515-8.
1996: Lindor K D; Jorgensen R A; Anderson M L; Gores G J; Hofmann A F; LaRusso N F
Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.
The American journal of gastroenterology 1996;91(3):511-5.
1996: Locke G R; Therneau T M; Ludwig J; Dickson E R; Lindor K D
Time course of histological progression in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1996;23(1):52-6.
1995: Lindor K D
Primary sclerosing cholangitis.
Revista de gastroenterología de México 1995;60(4 Suppl 2):S78-80.
1995: Lindor K D
Primary biliary cirrhosis.
Revista de gastroenterología de México 1995;60(4 Suppl 2):S75-7.
1995: Lindor K D; Dickson E R; Jorgensen R A; Anderson M L; Wiesner R H; Gores G J; Lange S M; Rossi S S; Hofmann A F; Baldus W P
The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1158-62.
1995: Jorgensen R A; Dickson E R; Hofmann A F; Rossi S S; Lindor K D
Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.
Gut 1995;36(6):935-8.
1995: Abdelmalek M; Ludwig J; Lindor K D
Two cases from the spectrum of nonalcoholic steatohepatitis.
Journal of clinical gastroenterology 1995;20(2):127-30.
1995: Lacerda M A; Ludwig J; Dickson E R; Jorgensen R A; Lindor K D
Antimitochondrial antibody-negative primary biliary cirrhosis.
The American journal of gastroenterology 1995;90(2):247-9.
1995: Lindor K D; Janes C H; Crippin J S; Jorgensen R A; Dickson E R
Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?
Hepatology (Baltimore, Md.) 1995;21(2):389-92.
1994: Spivey J R; Jorgensen R A; Gores G J; Lindor K D
Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis.
The American journal of gastroenterology 1994;89(11):2028-32.
1994: Laurin J M; Lindor K D
Primary biliary cirrhosis.
Digestive diseases (Basel, Switzerland) 1994;12(6):331-50.
1994: Laurin J M; DeSotel C K; Jorgensen R A; Dickson E R; Lindor K D
The natural history of abdominal pain associated with primary biliary cirrhosis.
The American journal of gastroenterology 1994;89(10):1840-3.
1994: Balan V; Dickson E R; Jorgensen R A; Lindor K D
Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.
Mayo Clinic proceedings. Mayo Clinic 1994;69(10):923-9.
1994: van Hoek B; Lindor K D; Murtaugh P A; Harrison J M; Krom R A; Wiesner R H; Nagorney D M
The role of portosystemic shunts for variceal bleeding in the liver transplantation era.
Archives of surgery (Chicago, Ill. : 1960) 1994;129(7):683-8.
1994: Lindor K D; Dickson E R; Baldus W P; Jorgensen R A; Ludwig J; Murtaugh P A; Harrison J M; Wiesner R H; Anderson M L; Lange S M
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
Gastroenterology 1994;106(5):1284-90.
1994: Crippin J S; Jorgensen R A; Dickson E R; Lindor K D
Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
The American journal of gastroenterology 1994;89(1):47-50.
1993: Lindor K D
Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis.
Seminars in liver disease 1993;13(4):367-73.
1993: Hashimoto E; Lindor K D; Homburger H A; Dickson E R; Czaja A J; Wiesner R H; Ludwig J
Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis.
Mayo Clinic proceedings. Mayo Clinic 1993;68(11):1049-55.
1993: Hurwich D B; Lindor K D; Hay J E; Gross J B; Kaese D; Rakela J
Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patients.
The American journal of gastroenterology 1993;88(8):1254-7.
1993: Taylor J; Lindor K
Metastatic prostate cancer simulating sclerosing cholangitis.
Journal of clinical gastroenterology 1993;16(2):143-5.
1992: Crippin J S; Gross J B; Lindor K D
Increased intracranial pressure and hepatic encephalopathy in chronic liver disease.
The American journal of gastroenterology 1992;87(7):879-82.
1992: Crippin J S; Lindor K D; Jorgensen R; Kottke B A; Harrison J M; Murtaugh P A; Dickson E R
Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?
Hepatology (Baltimore, Md.) 1992;15(5):858-62.
1992: Lindor K D; Fleming C R; Burnes J U; Nelson J K; Ilstrup D M
A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease.
Mayo Clinic proceedings. Mayo Clinic 1992;67(4):328-33.
1991: Hay J E; Lindor K D; Wiesner R H; Dickson E R; Krom R A; LaRusso N F
The metabolic bone disease of primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 1991;14(2):257-61.
1991: Lindor K D; Burnes J
Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report.
Gastroenterology 1991;101(1):250-3.
1991: Lindor K D; Wiesner R H; Colwell L J; Steiner B; Beaver S; LaRusso N F
The combination of prednisone and colchicine in patients with primary sclerosing cholangitis.
The American journal of gastroenterology 1991;86(1):57-61.
1990: Balasubramaniam K; Grambsch P M; Wiesner R H; Lindor K D; Dickson E R
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study.
Gastroenterology 1990;98(6):1567-71.
1990: Wiesner R H; Ludwig J; Lindor K D; Jorgensen R A; Baldus W P; Homburger H A; Dickson E R
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.
The New England journal of medicine 1990;322(20):1419-24.
1987: Lindor K D; Wiesner R H; LaRusso N F
Recent advances in the management of primary sclerosing cholangitis.
Seminars in liver disease 1987;7(4):322-7.
1987: Lindor K D; Hughes R W; Ilstrup D M; Jensen M D
Intragastric balloons in comparison with standard therapy for obesity--a randomized, double-blind trial.
Mayo Clinic proceedings. Mayo Clinic 1987;62(11):992-6.
1987: Lindor K D; Wiesner R H; Katzmann J A; LaRusso N F; Beaver S J
Lymphocyte subsets in primary sclerosing cholangitis.
Digestive diseases and sciences 1987;32(7):720-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Keith Lindor

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Keith Lindor (preview)

All Publications